These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 24878179)
1. Biodegradable nanoparticles for intracellular delivery of antimicrobial agents. Xie S; Tao Y; Pan Y; Qu W; Cheng G; Huang L; Chen D; Wang X; Liu Z; Yuan Z J Control Release; 2014 Aug; 187():101-17. PubMed ID: 24878179 [TBL] [Abstract][Full Text] [Related]
2. Cellular uptake pathway and drug release characteristics of drug-encapsulated glycol chitosan nanoparticles in live cells. Park S; Lee SJ; Chung H; Her S; Choi Y; Kim K; Choi K; Kwon IC Microsc Res Tech; 2010 Sep; 73(9):857-65. PubMed ID: 20232459 [TBL] [Abstract][Full Text] [Related]
3. Nanoparticle strategies for the oral delivery of insulin. Damgé C; Reis CP; Maincent P Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928 [TBL] [Abstract][Full Text] [Related]
4. Pharmacology of nanocarriers on the microscale: importance of uptake mechanisms and intracellular trafficking for efficient drug delivery. Hofmann D; Mailänder V Nanomedicine (Lond); 2013 Mar; 8(3):321-3. PubMed ID: 23477331 [No Abstract] [Full Text] [Related]
5. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers. Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622 [TBL] [Abstract][Full Text] [Related]
6. Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling. Raza K; Singh B; Singla S; Wadhwa S; Garg B; Chhibber S; Katare OP Mol Pharm; 2013 May; 10(5):1958-63. PubMed ID: 23544848 [TBL] [Abstract][Full Text] [Related]
7. Nanoparticles in drug delivery: past, present and future. Couvreur P Adv Drug Deliv Rev; 2013 Jan; 65(1):21-3. PubMed ID: 22580334 [TBL] [Abstract][Full Text] [Related]
8. Nano-inside-micro: Disease-responsive microgels with encapsulated nanoparticles for intracellular drug delivery to the deep lung. Wanakule P; Liu GW; Fleury AT; Roy K J Control Release; 2012 Sep; 162(2):429-37. PubMed ID: 22841795 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of nanocarriers with remote magnetic drug release control and enhanced drug delivery for intracellular targeting of cancer cells. Tung WL; Hu SH; Liu DM Acta Biomater; 2011 Jul; 7(7):2873-82. PubMed ID: 21439410 [TBL] [Abstract][Full Text] [Related]
10. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms. Forier K; Raemdonck K; De Smedt SC; Demeester J; Coenye T; Braeckmans K J Control Release; 2014 Sep; 190():607-23. PubMed ID: 24794896 [TBL] [Abstract][Full Text] [Related]
11. Intracellular trafficking of solid lipid nanoparticles and their distribution between cells through tunneling nanotubes. Kristl J; Plajnšek KT; Kreft ME; Janković B; Kocbek P Eur J Pharm Sci; 2013 Sep; 50(1):139-48. PubMed ID: 23628779 [TBL] [Abstract][Full Text] [Related]
12. A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery. Liu Y; Li K; Liu B; Feng SS Biomaterials; 2010 Dec; 31(35):9145-55. PubMed ID: 20864169 [TBL] [Abstract][Full Text] [Related]
13. Squalenoylation of Chitosan: A Platform for Drug Delivery? Lepeltier E; Loretz B; Desmaële D; Zapp J; Herrmann J; Couvreur P; Lehr CM Biomacromolecules; 2015 Sep; 16(9):2930-9. PubMed ID: 26221873 [TBL] [Abstract][Full Text] [Related]
14. Biodegradable chitosan nanoparticles in drug delivery for infectious disease. Landriscina A; Rosen J; Friedman AJ Nanomedicine (Lond); 2015 May; 10(10):1609-19. PubMed ID: 26008195 [TBL] [Abstract][Full Text] [Related]
15. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Torchilin VP Biopolymers; 2008; 90(5):604-10. PubMed ID: 18381624 [TBL] [Abstract][Full Text] [Related]
16. Nanoparticles and microparticles for skin drug delivery. Prow TW; Grice JE; Lin LL; Faye R; Butler M; Becker W; Wurm EM; Yoong C; Robertson TA; Soyer HP; Roberts MS Adv Drug Deliv Rev; 2011 May; 63(6):470-91. PubMed ID: 21315122 [TBL] [Abstract][Full Text] [Related]
17. Combination drug therapy via nanocarriers against infectious diseases. Walvekar P; Gannimani R; Govender T Eur J Pharm Sci; 2019 Jan; 127():121-141. PubMed ID: 30342173 [TBL] [Abstract][Full Text] [Related]
18. Development of nanoparticles for antimicrobial drug delivery. Zhang L; Pornpattananangku D; Hu CM; Huang CM Curr Med Chem; 2010; 17(6):585-94. PubMed ID: 20015030 [TBL] [Abstract][Full Text] [Related]
19. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133 [TBL] [Abstract][Full Text] [Related]
20. Oral delivery of proteins by biodegradable nanoparticles. Bakhru SH; Furtado S; Morello AP; Mathiowitz E Adv Drug Deliv Rev; 2013 Jun; 65(6):811-21. PubMed ID: 23608641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]